Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|May 24, 2015
Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experienceBenjamin Terrier, Agnès Dechartres, Charlotte Girard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two PatientsEtienne Crickx, Irène Machelart, Estibaliz Lazaro, et al.
Seminars in Arthritis and Rheumatism|December 18, 2025
Juvenile-onset mixed connective tissue disease: A multicenter retrospective cohort studyKevin Chevalier, Brigitte Bader-Meunier, Isabelle Kone-Paut, et al.
Rheumatology (Oxford, England)|December 21, 2020
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Matthias Papo, Renato A Sinico, Vítor Teixeira, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, et al.
Haematologica|February 16, 2015
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorderGuillaume Lefèvre, Marie-Christine Copin, Christophe Roumier, et al.
JAMA|February 1, 2021
Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in ChildrenNaïm Ouldali, Julie Toubiana, Denise Antona, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
JAMA Network Open|October 15, 2021
Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical TrialAurélien Dinh, Clara Duran, Jacques Ropers, et al.
Lancet (London, England)|March 28, 2021
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trialAurélien Dinh, Jacques Ropers, Clara Duran, et al.
Pageof 11